Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Nektar Therapeutics (NKTR) since 2015 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Nektar Therapeutics. (See page 1 of this report.) Table 2 shows the detailed insider transactions. This company's CIK number is 906709.
Total stock buying since 2015: $1,380,381.
Total stock sales since 2015: $232,957,638.
Total stock option exercises since 2015: $64,061,600.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 0 | $0 | 93,989 | $213,902 | 0 | $0 |
| 2024 | 0 | $0 | 383,431 | $446,447 | 0 | $0 |
| 2023 | 0 | $0 | 198,698 | $243,015 | 0 | $0 |
| 2022 | 0 | $0 | 287,002 | $1,338,751 | 0 | $0 |
| 2021 | 0 | $0 | 1,014,438 | $19,214,807 | 857,844 | $8,374,525 |
| 2020 | 0 | $0 | 272,486 | $5,487,307 | 147,500 | $1,286,775 |
| 2019 | 15,000 | $259,200 | 759,188 | $22,794,714 | 719,119 | $6,026,072 |
| 2018 | 5,000 | $290,431 | 1,255,625 | $101,982,187 | 1,060,964 | $11,098,812 |
| 2017 | 35,000 | $628,250 | 2,330,497 | $52,704,314 | 2,405,467 | $22,656,144 |
| 2016 | 15,000 | $202,500 | 687,748 | $10,451,012 | 786,583 | $3,364,205 |
| 2015 | 0 | $0 | 1,435,718 | $18,081,182 | 1,563,334 | $11,255,067 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2016-09-15 | Whitfield Roy A (Director) | Option Ex | 15,000 | .00 | 0 |
| 2016-09-01 | Robin Howard W (President & CEO) | Sale | 87,500 | 17.83 | 1,560,124 |
| 2016-09-01 | Robin Howard W (President & CEO) | Option Ex | 87,500 | 4.65 | 406,875 |
| 2016-08-16 | Doberstein Stephen K (SVP & Chief Scientific Officer) | Sale | 1,336 | 17.56 | 23,460 |
| 2016-08-16 | Hora Maninder (SVP Pharma Dev & Mfg Ops) | Sale | 3,305 | 17.56 | 58,035 |
| 2016-08-16 | Thomsen Jillian B. (SVP & Chief Accounting Officer) | Sale | 3,971 | 17.56 | 69,730 |
| 2016-08-16 | Nicholson John (SVP & Chief Operating Officer) | Sale | 3,317 | 17.56 | 58,246 |
| 2016-08-16 | Labrucherie Gil M (SVP & Chief Financial Officer) | Sale | 3,305 | 17.56 | 58,035 |
| 2016-08-16 | Gergel Ivan P. (SVP & Chief Medical Officer) | Sale | 1,685 | 17.56 | 29,588 |
| 2016-08-16 | Robin Howard W (President & CEO) | Sale | 11,817 | 17.56 | 207,506 |
| 2016-08-01 | Chess Robert (Director) | Sale | 5,000 | 17.26 | 86,300 |
| 2016-08-01 | Chess Robert (Director) | Option Ex | 5,000 | 5.15 | 25,750 |
| 2016-07-11 | Thomsen Jillian B. (SVP & Chief Accounting Officer) | Sale | 100,000 | 15.09 | 1,509,000 |
| 2016-07-11 | Thomsen Jillian B. (SVP & Chief Accounting Officer) | Option Ex | 100,000 | 4.65 | 465,000 |
| 2016-07-01 | Chess Robert (Director) | Sale | 5,000 | 14.10 | 70,500 |
| 2016-07-01 | Chess Robert (Director) | Option Ex | 5,000 | 5.15 | 25,750 |
| 2016-06-01 | Chess Robert (Director) | Sale | 5,000 | 15.50 | 77,500 |
| 2016-06-01 | Chess Robert (Director) | Option Ex | 5,000 | 5.15 | 25,750 |
| 2016-05-17 | Doberstein Stephen K (SVP & Chief Scientific Officer) | Sale | 339 | 13.58 | 4,603 |
| 2016-05-17 | Hora Maninder (SVP Pharma Dev & Mfg Ops) | Sale | 835 | 13.58 | 11,339 |
| 2016-05-17 | Thomsen Jillian B. (SVP & Chief Accounting Officer) | Sale | 724 | 13.58 | 9,831 |
| 2016-05-17 | Nicholson John (SVP & Chief Financial Officer) | Sale | 856 | 13.58 | 11,624 |
| 2016-05-17 | Labrucherie Gil M (SVP & General Counsel) | Sale | 836 | 13.58 | 11,352 |
| 2016-05-17 | Gergel Ivan P. (SVP & Chief Medical Officer) | Sale | 432 | 13.58 | 5,866 |
| 2016-05-17 | Robin Howard W (President & CEO) | Sale | 2,170 | 13.58 | 29,468 |
| 2016-05-16 | Doberstein Stephen K (SVP & Chief Scientific Officer) | Option Ex | 875 | .00 | 0 |
| 2016-05-16 | Hora Maninder (SVP Pharma Dev & Mfg Ops) | Option Ex | 2,167 | .00 | 0 |
| 2016-05-16 | Thomsen Jillian B. (SVP & Chief Accounting Officer) | Option Ex | 1,875 | .00 | 0 |
| 2016-05-16 | Nicholson John (SVP & Chief Financial Officer) | Option Ex | 2,167 | .00 | 0 |
| 2016-05-16 | Labrucherie Gil M (SVP & General Counsel) | Option Ex | 2,167 | .00 | 0 |
| 2016-05-16 | Gergel Ivan P. (SVP & Chief Medical Officer) | Option Ex | 1,250 | .00 | 0 |
| 2016-05-16 | Robin Howard W (President & CEO) | Option Ex | 5,625 | .00 | 0 |
| 2016-04-25 | Lingnau Lutz (Director) | Sale | 15,000 | 16.27 | 244,050 |
| 2016-04-25 | Lingnau Lutz (Director) | Option Ex | 15,000 | 8.37 | 125,549 |
| 2016-03-09 | Thomsen Jillian B. (SVP & Chief Accounting Officer) | Sale | 15,000 | 11.79 | 176,850 |
| 2016-03-09 | Thomsen Jillian B. (SVP & Chief Accounting Officer) | Option Ex | 15,000 | 6.65 | 99,750 |
| 2016-02-17 | Doberstein Stephen K (SVP & Chief Scientific Officer) | Sale | 390 | 11.92 | 4,648 |
| 2016-02-17 | Hora Maninder (SVP Pharma Dev & Mfg Ops) | Sale | 963 | 11.92 | 11,478 |
| 2016-02-17 | Thomsen Jillian B. (SVP & Chief Accounting Officer) | Sale | 716 | 11.92 | 8,534 |
| 2016-02-17 | Nicholson John (SVP & Chief Financial Officer) | Sale | 963 | 11.92 | 11,478 |
| 2016-02-17 | Labrucherie Gil M (SVP & General Counsel) | Sale | 827 | 11.92 | 9,857 |
| 2016-02-17 | Gergel Ivan P. (SVP & Chief Medical Officer) | Sale | 556 | 11.92 | 6,627 |
| 2016-02-17 | Robin Howard W (President & CEO) | Sale | 2,147 | 11.92 | 25,592 |
| 2016-02-16 | Doberstein Stephen K (SVP & Chief Scientific Officer) | Option Ex | 875 | .00 | 0 |
| 2016-02-16 | Hora Maninder (SVP Pharma Dev & Mfg Ops) | Option Ex | 2,166 | .00 | 0 |
| 2016-02-16 | Thomsen Jillian B. (SVP & Chief Accounting Officer) | Option Ex | 1,875 | .00 | 0 |
| 2016-02-16 | Nicholson John (SVP & Chief Financial Officer) | Option Ex | 2,166 | .00 | 0 |
| 2016-02-16 | Labrucherie Gil M (SVP & General Counsel) | Option Ex | 2,166 | .00 | 0 |
| 2016-02-16 | Gergel Ivan P. (SVP & Chief Medical Officer) | Option Ex | 1,250 | .00 | 0 |
| 2016-02-16 | Robin Howard W (President & CEO) | Option Ex | 5,625 | .00 | 0 |
| 2016-01-20 | Lingnau Lutz (Director) | Sale | 15,000 | 14.51 | 217,650 |
| 2016-01-20 | Lingnau Lutz (Director) | Option Ex | 15,000 | 5.15 | 77,250 |
| 2016-01-19 | Thomsen Jillian B. (SVP & Chief Accounting Officer) | Sale | 15,000 | 14.12 | 211,800 |
| 2016-01-19 | Thomsen Jillian B. (SVP & Chief Accounting Officer) | Option Ex | 15,000 | 6.65 | 99,750 |
| 2016-01-19 | Labrucherie Gil M (SVP & General Counsel) | Sale | 11,667 | 14.12 | 164,738 |
| 2016-01-19 | Labrucherie Gil M (SVP & General Counsel) | Option Ex | 11,667 | 6.46 | 75,368 |
| 2016-01-19 | Robin Howard W (President & CEO) | Sale | 66,667 | 14.12 | 941,338 |
| 2016-01-19 | Robin Howard W (President & CEO) | Option Ex | 66,667 | 6.46 | 430,668 |
| 2015-12-04 | Kuebler Christopher A (Director) | Sale | 15,000 | 15.82 | 237,300 |
| 2015-12-04 | Kuebler Christopher A (Director) | Option Ex | 15,000 | 5.15 | 77,250 |
| 2015-12-03 | Thomsen Jillian B. (SVP & Chief Accounting Officer) | Sale | 15,000 | 15.87 | 238,050 |
| 2015-12-03 | Thomsen Jillian B. (SVP & Chief Accounting Officer) | Option Ex | 15,000 | 6.65 | 99,750 |
| 2015-12-03 | Labrucherie Gil M (SVP & General Counsel) | Sale | 45,001 | 15.87 | 714,165 |
| 2015-12-03 | Labrucherie Gil M (SVP & General Counsel) | Option Ex | 45,001 | 6.72 | 302,406 |
| 2015-12-03 | Robin Howard W (President & CEO) | Sale | 125,001 | 15.87 | 1,983,765 |
| 2015-12-03 | Robin Howard W (President & CEO) | Option Ex | 125,001 | 6.72 | 840,006 |
| 2015-11-20 | Wang Susan (Director) | Sale | 49,500 | 15.02 | 743,490 |
| 2015-11-20 | Wang Susan (Director) | Option Ex | 49,500 | 7.19 | 355,905 |
| 2015-11-19 | Wang Susan (Director) | Sale | 15,128 | 15.02 | 227,222 |
| 2015-11-19 | Wang Susan (Director) | Option Ex | 15,128 | 5.14 | 77,757 |
| 2015-11-18 | Wang Susan (Director) | Sale | 20,372 | 15.00 | 305,580 |
| 2015-11-18 | Wang Susan (Director) | Option Ex | 20,372 | 6.75 | 137,612 |
| 2015-11-11 | Thomsen Jillian B. (SVP & Chief Accounting Officer) | Sale | 15,000 | 13.52 | 202,800 |
| 2015-11-11 | Thomsen Jillian B. (SVP & Chief Accounting Officer) | Option Ex | 15,000 | 6.65 | 99,750 |
| 2015-11-11 | Labrucherie Gil M (SVP & General Counsel) | Sale | 45,000 | 13.52 | 608,400 |
| 2015-11-11 | Labrucherie Gil M (SVP & General Counsel) | Option Ex | 45,000 | 6.72 | 302,400 |
| 2015-11-11 | Robin Howard W (President & CEO) | Sale | 125,000 | 13.52 | 1,690,000 |
| 2015-11-11 | Robin Howard W (President & CEO) | Option Ex | 125,000 | 6.72 | 840,000 |
| 2015-10-28 | Lingnau Lutz (Director) | Sale | 12,500 | 12.00 | 150,000 |
| 2015-10-28 | Lingnau Lutz (Director) | Option Ex | 12,500 | 6.65 | 83,125 |
| 2015-10-15 | Greer R Scott (Director) | Option Ex | 32,500 | 11.34 | 368,550 |
| 2015-10-06 | Thomsen Jillian B. (SVP & Chief Accounting Officer) | Sale | 15,000 | 10.99 | 164,850 |
| 2015-10-06 | Thomsen Jillian B. (SVP & Chief Accounting Officer) | Option Ex | 15,000 | 6.65 | 99,750 |
| 2015-10-06 | Labrucherie Gil M (SVP & General Counsel) | Sale | 45,000 | 10.99 | 494,550 |
| 2015-10-06 | Labrucherie Gil M (SVP & General Counsel) | Option Ex | 45,000 | 6.72 | 302,400 |
| 2015-10-06 | Robin Howard W (President & CEO) | Sale | 125,000 | 10.99 | 1,373,750 |
| 2015-10-06 | Robin Howard W (President & CEO) | Option Ex | 125,000 | 6.72 | 840,000 |
| 2015-09-23 | Thomsen Jillian B. (SVP & Chief Accounting Officer) | Sale | 10,000 | 13.04 | 130,399 |
| 2015-09-23 | Thomsen Jillian B. (SVP & Chief Accounting Officer) | Option Ex | 10,000 | 6.65 | 66,500 |
| 2015-09-23 | Labrucherie Gil M (SVP & General Counsel) | Sale | 44,999 | 13.04 | 586,786 |
| 2015-09-23 | Labrucherie Gil M (SVP & General Counsel) | Option Ex | 44,999 | 6.72 | 302,393 |
| 2015-09-23 | Robin Howard W (President & CEO) | Sale | 124,999 | 13.04 | 1,629,986 |
| 2015-09-23 | Robin Howard W (President & CEO) | Option Ex | 124,999 | 6.72 | 839,993 |
| 2015-09-11 | Whitfield Roy A (Director) | Option Ex | 15,000 | 8.81 | 132,150 |
| 2015-08-13 | Labrucherie Gil M (SVP & General Counsel) | Sale | 33,333 | 10.89 | 362,996 |
| 2015-08-13 | Labrucherie Gil M (SVP & General Counsel) | Option Ex | 33,333 | 6.98 | 232,664 |
| 2015-08-13 | Robin Howard W (President & CEO) | Sale | 58,333 | 10.89 | 635,246 |
| 2015-08-13 | Robin Howard W (President & CEO) | Option Ex | 58,333 | 6.98 | 407,164 |
| 2015-08-12 | Nicholson John (SVP & Chief Financial Officer) | Sale | 69,976 | 10.55 | 738,596 |
| 2015-08-12 | Nicholson John (SVP & Chief Financial Officer) | Option Ex | 90,000 | 6.72 | 604,800 |
| 2015-08-11 | Nicholson John (SVP & Chief Financial Officer) | Sale | 249,908 | 10.83 | 2,706,503 |
| 2015-08-11 | Nicholson John (SVP & Chief Financial Officer) | Option Ex | 295,000 | 8.24 | 2,430,800 |
| 2015-07-24 | Krivulka Joseph J (Director) | Option Ex | 15,000 | 8.81 | 132,150 |
| 2015-07-14 | Labrucherie Gil M (SVP & General Counsel) | Sale | 33,334 | 11.78 | 392,674 |
| 2015-07-14 | Labrucherie Gil M (SVP & General Counsel) | Option Ex | 33,334 | 6.98 | 232,671 |
| 2015-07-14 | Robin Howard W (President & CEO) | Sale | 58,334 | 11.78 | 687,174 |
| 2015-07-14 | Robin Howard W (President & CEO) | Option Ex | 58,334 | 6.98 | 407,171 |
| 2015-06-29 | Wang Susan (Director) | Sale | 30,000 | 12.70 | 381,000 |
| 2015-06-29 | Wang Susan (Director) | Option Ex | 30,000 | 6.98 | 209,400 |
| 2015-06-19 | Chess Robert (Director) | Sale | 15,000 | 11.81 | 177,150 |
| 2015-06-19 | Chess Robert (Director) | Option Ex | 15,000 | 8.81 | 132,150 |
| 2015-06-15 | Lingnau Lutz (Director) | Sale | 25,000 | 11.15 | 278,750 |
| 2015-06-15 | Lingnau Lutz (Director) | Option Ex | 25,000 | 6.65 | 166,250 |
| 2015-01-13 | Kuebler Christopher A (Director) | Sale | 15,000 | 16.00 | 240,000 |
| 2015-01-13 | Kuebler Christopher A (Director) | Option Ex | 15,000 | 8.81 | 132,150 |
Insider trading activities including stock purchases, stock sales, and option exercises of NKTR listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Nektar Therapeutics (symbol NKTR, CIK number 906709) see the Securities and Exchange Commission (SEC) website.